Abstract:This study used an immunohistochemical technique to examine the expression of human telomerase reverse transcriptase (hTERT) protein in 82 specimens of OSCC, 116 specimens of oral epithelial dysplasia (OED), and 21 specimens of normal oral mucosa (NOM). The cytoplasmic and nuclear hTERT staining intensity (SI; 0, no staining; 1, weak; 2, moderate; 3, strong), labeling indices (LIs, defined as the percentage of positive cells in total cells), and labeling scores (LSs, defined as LI×SI) in OSCC, OED, and NOM samples were calculated and compared among groups. The correlation between the cytoplasmic or nuclear hTERT LS in OSCCs and clinicopathological parameters or survival of OSCC patients was analyzed statistically. The mean cytoplasmic hTERT LSs increased significantly from NOM (87±17%) through OED (95±18%) to OSCC samples (114±33%, p=0.000). The mean nuclear hTERT LSs also increased from NOM (80±14%) to OED (91±20%) and then decreased to OSCC samples (86±35%) with no statistically significant difference among the 3 groups. A significant correlation was found between the higher mean cytoplasmic hTERT LSs and OSCCs occurring in male patients (p=0.023), with larger tumor sizes (T3 and T4, p=0.048), with more advanced clinical stages (stages 3 and 4, p=0.033), or from patients with areca quid chewing (p= 0.029), cigarette smoking (p=0.027), or alcohol drinking habit (p=0.025). In addition, OSCC patients with nuclear hTERT LSs greater than 100% were prone to have a higher recurrence rate (p=0.044) and a lower 5-year survival rate (p=0.011). Our results indicate that the increased expression of hTERT protein is an early event in oral carcinogenesis and hTERT may be a biomarker for OSCCs. Measuring the amount of cytoplasmic or nuclear expression of hTERT in OSCC samples may predict the oral cancer progression, recurrence, and prognosis in Taiwan.

Expression of telomerase and p53 in ameloblastoma]

Expression of telomerase and p 53 in ameloblastoma of the jaw

Expression of Telomerase Htrand Htert Gene in Human Amelobastoma

Expression of human telomerase RNA in ameloblastoma

Expression of pRb and E2F-1 and telomerase activity in ameloblastoma

Expression of Cyclin D1 and Its Inhibitors and Htert in Ameloblastoma

Expression and significance of hTERT, c-fos and c-jun in ameloblastoma

Expression of Telomerase Activity and c-myc and Stimulatory Protein 1 in Human Ameloblastoma

Expression of P21~(waf1), P27~(kip1) and Cyclin E in Ameloblastoma

The expression of BMP-2 mRNA in ameloblastoma of the jaw bone

[Expression of HOXC13 in Ameloblastoma].

Immunohistochemical Analysis of P57(kip2), P53 and Hsp60 Expressions in Premalignant and Malignant Oral Tissues

Expressions of P53 and Nm23 Proteins in Oral Squamous Cell Carcinoma

[Research on the Expression of C-Myc Mrna in Ameloblastoma].

Expression of Midkine in Ameloblastomas and Its Correlation with Clinicopathologic Parameters.

Detection and Significance of Centrosome in Amelobalstomas

Differential expression of apoptosis-related proteins in various cellular components of ameloblastomas.

Association of MDM2 Overexpression in Ameloblastomas with MDM2 Amplification and BRAFV600E Expression

Exploring protein profiles and hub genes in ameloblastoma

[Expression of HOX C13 in odontogenic tumors].

Expression of human telomerase reverse transcriptase (hTERT) protein is significantly associated with the progression, recurrence and prognosis of oral squamous cell carcinoma in Taiwan